Defining a Target Population to Effectively Test a Neuroprotective Drug.
Olivé-Gadea M, Requena M, Campos D, Garcia-Tornel A, Deck M, Muchada M, Boned S, Rodríguez N, Juega J, Rodríguez-Luna D, Pagola J, Rubiera M, Hernández-Jiménez M, Molina CA, Ribo M.
Olivé-Gadea M, et al.
Stroke. 2021 Jan;52(2):505-510. doi: 10.1161/STROKEAHA.120.032025. Epub 2021 Jan 11.
Stroke. 2021.
PMID: 33423513